Short answer

When designing pharmaceutical production systems, prioritize modularity, user-friendliness, and robust quality control to facilitate on-demand, personalized medicine manufacturing using FDM.

Field
Commercial Production
Source
Polymers (2024)
Method
Literature Review
Evidence
Strong effect

FDM 3D printing offers a flexible and efficient method for creating customized solid dosage forms, including complex formulations like amorphous solid dispersions and enteric-coated tablets. This commercial production research insight is drawn from a 2024 study published in Polymers. Using Literature review, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing pharmaceutical production systems, prioritize modularity, user-friendliness, and robust quality control to facilitate on-demand, personalized medicine manufacturing using FDM.

Study
Commercial ProductionRecentStrong effect

Fused Deposition Modeling (FDM) enables personalized pharmaceutical production at the point of care.

FDM 3D printing offers a flexible and efficient method for creating customized solid dosage forms, including complex formulations like amorphous solid dispersions and enteric-coated tablets.

Polymers · 2024

01

Key Findings

  • 01FDM 3D printing can produce complex tablet formulations such as amorphous solid dispersions and enteric-coated tablets.
  • 02The technology supports the development of personalized medicines, allowing for customized dosages and combinations.
  • 03Current constraints include regulatory hurdles, material science limitations, and the need for robust software and quality control systems.
02

Application

Design takeaway

When designing pharmaceutical production systems, prioritize modularity, user-friendliness, and robust quality control to facilitate on-demand, personalized medicine manufacturing using FDM.

How to apply

Consider how FDM 3D printing could be integrated into a pharmacy workflow to produce patient-specific medication formulations, addressing challenges like complex drug combinations or tailored release profiles.

Project actions

  • 01Investigate specific drug-polymer interactions for FDM printing.
  • 02Explore the regulatory landscape for 3D printed pharmaceuticals.
  • 03Consider the user interface and workflow for pharmacists operating the 3D printer.
03

Method & Evidence

AimTo explore the potential of FDM 3D printing for the production of customized pharmaceutical dosage forms and identify current limitations for its widespread adoption.
MethodLiterature Review
ProcedureThe authors reviewed existing research and technological capabilities of FDM 3D printing in the context of pharmaceutical applications, focusing on its suitability for creating various tablet types and its implications for personalized medicine delivery, particularly for gastrointestinal applications.
ContextPharmaceutical manufacturing and healthcare

Variables

IV["FDM 3D printing parameters (e.g., temperature, speed, layer height)","Drug-polymer combinations"]
DV["Tablet characteristics (e.g., dissolution rate, drug release profile, mechanical strength)","Production efficiency","Cost-effectiveness"]
CV["Type of drug being formulated","Environmental conditions of the printing facility"]
04

Strengths & Limitations

Strengths

  • +Highlights the potential for personalized medicine.
  • +Discusses specific tablet types that can be produced.
  • +Identifies key areas for future development.

Limitations

The current technology may have limitations in terms of printing speed, material compatibility, and regulatory approval for actual drug products.

Reliability & validity

The reliability of FDM printing can be assessed by repeating print runs under identical conditions and measuring the consistency of tablet dimensions and properties. Validity is addressed by comparing the printed tablet's drug release profile to desired therapeutic targets or established benchmarks.

Think critically

Beyond personalized dosages, what other aspects of pharmaceutical delivery (e.g., drug combinations, release profiles, patient adherence) can FDM 3D printing uniquely address, and what are the primary design challenges in achieving these?

05

Design Principles

"On-demand, personalized manufacturing can be achieved through adaptable additive manufacturing technologies."

This technology has the potential to revolutionize pharmaceutical manufacturing by enabling personalized medicine production directly within pharmacies or hospitals. This shift could lead to more cost-effective and tailored patient treatments, moving away from mass production models.

06

What This Means for Your Design

3D printing with FDM can make custom medicines right at the pharmacy, which is good for patients who need special doses or combinations of drugs.

How to use in your project

  • 1.Use this research to justify the exploration of additive manufacturing for custom product development in your design project.
  • 2.Cite the potential for personalized production as a driver for your design choices.
07

Add to My Project

08

Quick Cite

Paragraph starter

The advent of Fused Deposition Modeling (FDM) 3D printing presents a significant opportunity for the pharmaceutical industry to move towards personalized medicine production. This technology allows for the on-demand fabrication of complex solid dosage forms, such as amorphous solid dispersions and enteric-coated tablets, directly at the point of care, such as pharmacies or hospital dispensaries. By enabling customized drug formulations, FDM 3D printing has the potential to enhance therapeutic outcomes and improve cost-effectiveness in healthcare delivery.

09

Source

Polymers

Status of Polymer Fused Deposition Modeling (FDM)-Based Three-Dimensional Printing (3DP) in the Pharmaceutical Industry

journal · 2024

View source

Questions About This Research

What does the research say about fused deposition modeling (fdm) enables personalized pharmaceutical production at the point of care?
When designing pharmaceutical production systems, prioritize modularity, user-friendliness, and robust quality control to facilitate on-demand, personalized medicine manufacturing using FDM. Evidence: Polymers (2024).
Why does "Fused Deposition Modeling (FDM) enables personalized pharmaceutical production at the point of care." matter for design?
This technology has the potential to revolutionize pharmaceutical manufacturing by enabling personalized medicine production directly within pharmacies or hospitals. This shift could lead to more cost-effective and tailored patient treatments, moving away from mass production models.
How can designers apply this research?
When designing pharmaceutical production systems, prioritize modularity, user-friendliness, and robust quality control to facilitate on-demand, personalized medicine manufacturing using FDM.
What were the main findings?
FDM 3D printing can produce complex tablet formulations such as amorphous solid dispersions and enteric-coated tablets.. The technology supports the development of personalized medicines, allowing for customized dosages and combinations.. Current constraints include regulatory hurdles, material science limitations, and the need for robust software and quality control systems.
What research method was used?
Literature Review.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2024 journal from Polymers.
What should I do differently in my next project?
Consider how FDM 3D printing could be integrated into a pharmacy workflow to produce patient-specific medication formulations, addressing challenges like complex drug combinations or tailored release profiles.
What are the limitations?
The review focuses on FDM and may not encompass all relevant 3D printing technologies for pharmaceuticals. The economic viability and scalability for mass production beyond personalized doses are not deeply explored.